WALTHAM, MA-Compound Therapeutics Inc. is relocating its corporate headquarters with a 17,500 sf lease at 100 Beaver St. The privately held biotechnology company is moving from 1365 Main St.

The new space represents an expansion from the company’s previous location. Compound Therapeutics was represented in the transaction by Jonathan Varholak and Michael Frisoli, partners at Richards Barry Joyce & Partners. The company is sub-leasing the space from Oscient Pharmaceuticals, which was represented by Spaulding & Slye Colliers. Oscient Pharmaceuticals was formed through the merger of Genome Therapeutics and Genesoft Pharmaceuticals.

“The building at 100 Beaver Street provides Compound Therapeutics with an excellent second-generation biotechnology space in the suburban market,” says Varholak. “They are also able to take advantage of the current market rates, while staying in Waltham, which is becoming a popular biotechnology center.”

According to Spaulding & Slye Collier’s most recent statistics, the area’s overall availability rate for its research and development market is at 41%. Excess sublease space continues to drive some of that vacancy as the vacancy rate for direct space is at 33%. Leases rates for this deal were not available, but the average asking rent for research and development space in the area is about $14 per sf. Sublease deals tend to command a lower rate.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Dig Deeper



Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.